Stroke trials in Latvia
5 of 6 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleStroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- Where
- Daugavpils, Liepaja, Riga
- Age
- 18 years and over
- People
- 2,628 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07430956 · EU 2025-521618-25-00 - Phase 3Taking peopleStroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Where
- Daugavpils, Liepaja, Ogre, Riga, Valmiera
- Age
- 18 years and over
- People
- 15,364 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07626411 · EU 2025-521617-97-00 - Phase 2/3Taking peopleOptimizing Reperfusion to Improve Outcomes and Neurologic Function (ORION)
- Where
- Daugavpils, Riga
- Age
- 18 years and over
- People
- 210 worldwide
- Run by
- Corxel Pharmaceuticals Co. Ltd.
See details and how to join2024-519521-37-01 · EU 2024-519521-37-01 - Phase 2/3Taking peopleOptimizing Reperfusion to Improve Outcomes and Neurologic Function
- Where
- Daugavpils, Riga
- Age
- 18 years to 90 years
- People
- 740 worldwide
- Run by
- Corxel Pharmaceuticals
See details and how to joinNCT06990867 - No phaseNot yet taking people in LatviaHome-Based Stroke Rehabilitation Using Enriched Environments (PEER-HOMEcare)
- Where
- Riga
- Age
- 18 years and over
- People
- 45 worldwide
- Run by
- Norwegian School of Sport Sciences
See details and how to joinNCT07517120